Vanderbilt-Ingram Cancer Center

August 1, 2025

Study reports final clinical trial data for advanced kidney cancer treatment

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.

(photo by Erin O. Smith)
July 29, 2025

Program provides path for aspiring oncologists and cancer researchers

The program was established in 2023 with financial support from the American Cancer Society, and Vanderbilt-Ingram had an inaugural class of four fellows.

July 22, 2025

Study provides new data on COVID outcomes for cancer patients 

Death incidence was highest in patients with lymphoma, intermediate in patients with acute leukemia and lung cancer, and lowest in patients with other solid tumors or with blood cancers other than lymphoma.

July 3, 2025

Stand Up To Cancer heads to Nashville for ninth roadblock fundraising special uniting country music and cancer research

One-hour event will feature Dolly Parton and Sheryl Crow, with Crow also hosting.

June 17, 2025

Drug shows safety, efficacy for precancerous stomach lesions

The drug also showed promise that it could be the first therapeutic intervention against precancerous lesions in the stomach.

Patient Monroe Peterson inspired the creation of the MVP Challenge to raise funds supporting children’s cancer treatment and research.
June 12, 2025

The real MVP: Fitness challenge raises funds in honor of 4-year-old cancer patient

The fitness challenge raised funds to support pediatric cancer research, training and care at Monroe Carell Jr. Children’s Hospital at Vanderbilt.